25 XP   0   0   10

3SBio Inc
Buy, Hold or Sell?

Let's analyse 3sbio together

PenkeI guess you are interested in 3SBio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of 3SBio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about 3SBio Inc

I send you an email if I find something interesting about 3SBio Inc.

Quick analysis of 3sbio (30 sec.)










What can you expect buying and holding a share of 3sbio? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.09
When do you have the money?
1 year
How often do you get paid?
80.0%

What is your share worth?

Current worth
HK$5.74
Expected worth in 1 year
HK$7.76
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
HK$2.76
Return On Investment
45.6%

For what price can you sell your share?

Current Price per Share
HK$6.05
Expected price per share
HK$4.7960215010142 - HK$6.52
How sure are you?
50%

1. Valuation of 3sbio (5 min.)




Live pricePrice per Share (EOD)

HK$6.05

Intrinsic Value Per Share

HK$1.27 - HK$5.15

Total Value Per Share

HK$7.01 - HK$10.89

2. Growth of 3sbio (5 min.)




Is 3sbio growing?

Current yearPrevious yearGrowGrow %
How rich?$1.7b$1.6b$101.4m5.7%

How much money is 3sbio making?

Current yearPrevious yearGrowGrow %
Making money$264.1m$227.8m$36.3m13.8%
Net Profit Margin27.9%25.9%--

How much money comes from the company's main activities?

3. Financial Health of 3sbio (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#38 / 1010

Most Revenue
#20 / 1010

Most Profit
#15 / 1010

Most Efficient
#59 / 1010

What can you expect buying and holding a share of 3sbio? (5 min.)

Welcome investor! 3sbio's management wants to use your money to grow the business. In return you get a share of 3sbio.

What can you expect buying and holding a share of 3sbio?

First you should know what it really means to hold a share of 3sbio. And how you can make/lose money.

Speculation

The Price per Share of 3sbio is HK$6.05. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of 3sbio.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in 3sbio, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$5.74. Based on the TTM, the Book Value Change Per Share is HK$0.50 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-0.32 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.18 per quarter.
Based on historical numbers we can estimate the returns while holding a share of 3sbio.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.111.8%0.111.8%0.091.5%0.071.2%0.050.8%
Usd Book Value Change Per Share0.061.1%0.061.1%-0.04-0.7%0.061.1%0.071.1%
Usd Dividend Per Share0.020.4%0.020.4%0.000.0%0.010.1%0.010.2%
Usd Total Gains Per Share0.091.5%0.091.5%-0.04-0.7%0.071.2%0.081.3%
Usd Price Per Share1.06-1.06-0.83-1.07-0.97-
Price to Earnings Ratio9.78-9.78-9.19-16.35-19.21-
Price-to-Total Gains Ratio12.04-12.04--20.06-6.17-10.92-
Price to Book Ratio1.45-1.45-1.24-1.78-2.06-
Price-to-Total Gains Ratio12.04-12.04--20.06-6.17-10.92-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.772585
Number of shares1294
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share0.060.06
Usd Total Gains Per Share0.090.07
Gains per Quarter (1294 shares)113.9690.93
Gains per Year (1294 shares)455.84363.71
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
112233444634330354
224466790268660718
3366100113581019901082
44891335181413513201446
56111669227016916491810
67332002272620319792174
78552336318223723092538
89772670363827126392902
910993003409430429693266
1012213337455033832993630

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.07.058.8%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%7.03.00.070.0%13.04.00.076.5%
Dividend per Share1.00.00.0100.0%1.00.02.033.3%3.00.02.060.0%8.00.02.080.0%8.00.09.047.1%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%15.02.00.088.2%

Fundamentals of 3sbio

About 3SBio Inc

3SBio Inc., an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; Cipterbin, an anti-HER2 monoclonal antibody for the treatment of HER2-positive metastatic breast cancer in combination with chemotherapy; Interferon, a human interferon a2a for injection; and Inleusin, for the treatment of renal cell carcinoma, melanoma, thoracic fluid build-up caused by cancer and tuberculosis. It also offers YISAIPU, the receptor-antibody fusion tumor necrosis factor inhibitor; Mendi-minoxidil tincture, an OTC external medicine for treating hair loss; EPIAO and SEPO, an erythropoietin injection; SPARIN, an injectable low-molecular-weight heparin calcium; and Xenopax, a recombinant humanized anti-cd25 monoclonal antibody injection for prevention of acute rejection after renal transplantation. In addition, the company provides TPO-105 Pediatric ITP; SSS12 Cinacalcet hydrochloride; SSS13 Sevelamer carbonate; 301S TNFR-Fc protein; AP506 Apremilast; SSS32 Tofacitinib; and MN709 Minoxidil Foam. Further, the company provides trading, project management and consultation, technology, sports, financial, investment advisory, and agricultural services. It has collaboration agreements with companies, such as Toray Industries Inc, and Toray. The company was founded in 1993 and is headquartered in Shenyang, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-15 23:17:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of 3SBio Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit 3sbio earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare 3sbio to the Biotechnology industry mean.
  • A Net Profit Margin of 27.9% means that $0.28 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of 3SBio Inc:

  • The MRQ is 27.9%. The company is making a huge profit. +2
  • The TTM is 27.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ27.9%TTM27.9%0.0%
TTM27.9%YOY25.9%+2.0%
TTM27.9%5Y23.0%+4.9%
5Y23.0%10Y23.4%-0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ27.9%-207.2%+235.1%
TTM27.9%-216.8%+244.7%
YOY25.9%-282.3%+308.2%
5Y23.0%-436.8%+459.8%
10Y23.4%-597.3%+620.7%
1.1.2. Return on Assets

Shows how efficient 3sbio is using its assets to generate profit.

  • Above 5% is considered healthy but always compare 3sbio to the Biotechnology industry mean.
  • 8.7% Return on Assets means that 3sbio generated $0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of 3SBio Inc:

  • The MRQ is 8.7%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 8.7%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ8.7%TTM8.7%0.0%
TTM8.7%YOY8.6%+0.1%
TTM8.7%5Y7.6%+1.1%
5Y7.6%10Y7.9%-0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.7%-13.3%+22.0%
TTM8.7%-12.8%+21.5%
YOY8.6%-11.6%+20.2%
5Y7.6%-13.8%+21.4%
10Y7.9%-15.6%+23.5%
1.1.3. Return on Equity

Shows how efficient 3sbio is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare 3sbio to the Biotechnology industry mean.
  • 14.8% Return on Equity means 3sbio generated $0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of 3SBio Inc:

  • The MRQ is 14.8%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 14.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.8%TTM14.8%0.0%
TTM14.8%YOY13.5%+1.3%
TTM14.8%5Y12.2%+2.6%
5Y12.2%10Y13.4%-1.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.8%-16.9%+31.7%
TTM14.8%-16.1%+30.9%
YOY13.5%-14.9%+28.4%
5Y12.2%-19.3%+31.5%
10Y13.4%-20.1%+33.5%

1.2. Operating Efficiency of 3SBio Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient 3sbio is operating .

  • Measures how much profit 3sbio makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare 3sbio to the Biotechnology industry mean.
  • An Operating Margin of 27.8% means the company generated $0.28  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of 3SBio Inc:

  • The MRQ is 27.8%. The company is operating very efficient. +2
  • The TTM is 27.8%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ27.8%TTM27.8%0.0%
TTM27.8%YOY26.4%+1.4%
TTM27.8%5Y27.5%+0.4%
5Y27.5%10Y29.3%-1.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ27.8%-298.0%+325.8%
TTM27.8%-238.5%+266.3%
YOY26.4%-288.4%+314.8%
5Y27.5%-486.2%+513.7%
10Y29.3%-628.4%+657.7%
1.2.2. Operating Ratio

Measures how efficient 3sbio is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.88 means that the operating costs are $0.88 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of 3SBio Inc:

  • The MRQ is 0.879. The company is less efficient in keeping operating costs low.
  • The TTM is 0.879. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.879TTM0.8790.000
TTM0.879YOY0.879+0.000
TTM0.8795Y0.824+0.056
5Y0.82410Y0.766+0.058
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8793.235-2.356
TTM0.8793.310-2.431
YOY0.8793.838-2.959
5Y0.8245.679-4.855
10Y0.7667.823-7.057

1.3. Liquidity of 3SBio Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if 3sbio is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.44 means the company has $5.44 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of 3SBio Inc:

  • The MRQ is 5.441. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.441. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.441TTM5.4410.000
TTM5.441YOY5.486-0.045
TTM5.4415Y4.213+1.228
5Y4.21310Y4.010+0.203
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4413.863+1.578
TTM5.4414.169+1.272
YOY5.4865.337+0.149
5Y4.2136.122-1.909
10Y4.0106.434-2.424
1.3.2. Quick Ratio

Measures if 3sbio is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare 3sbio to the Biotechnology industry mean.
  • A Quick Ratio of 7.30 means the company can pay off $7.30 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of 3SBio Inc:

  • The MRQ is 7.296. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.296. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.296TTM7.2960.000
TTM7.296YOY5.604+1.693
TTM7.2965Y4.510+2.786
5Y4.51010Y3.597+0.913
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.2963.504+3.792
TTM7.2963.991+3.305
YOY5.6045.371+0.233
5Y4.5106.088-1.578
10Y3.5976.395-2.798

1.4. Solvency of 3SBio Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of 3sbio assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare 3sbio to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.41 means that 3sbio assets are financed with 41.0% credit (debt) and the remaining percentage (100% - 41.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of 3SBio Inc:

  • The MRQ is 0.410. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.410. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.410TTM0.4100.000
TTM0.410YOY0.364+0.047
TTM0.4105Y0.338+0.072
5Y0.33810Y0.341-0.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4100.339+0.071
TTM0.4100.337+0.073
YOY0.3640.271+0.093
5Y0.3380.368-0.030
10Y0.3410.388-0.047
1.4.2. Debt to Equity Ratio

Measures if 3sbio is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare 3sbio to the Biotechnology industry mean.
  • A Debt to Equity ratio of 69.6% means that company has $0.70 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of 3SBio Inc:

  • The MRQ is 0.696. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.696. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.696TTM0.6960.000
TTM0.696YOY0.571+0.125
TTM0.6965Y0.546+0.150
5Y0.54610Y0.603-0.056
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6960.392+0.304
TTM0.6960.403+0.293
YOY0.5710.335+0.236
5Y0.5460.427+0.119
10Y0.6030.461+0.142

2. Market Valuation of 3SBio Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings 3sbio generates.

  • Above 15 is considered overpriced but always compare 3sbio to the Biotechnology industry mean.
  • A PE ratio of 9.78 means the investor is paying $9.78 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of 3SBio Inc:

  • The EOD is 7.132. Based on the earnings, the company is cheap. +2
  • The MRQ is 9.785. Based on the earnings, the company is underpriced. +1
  • The TTM is 9.785. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD7.132MRQ9.785-2.652
MRQ9.785TTM9.7850.000
TTM9.785YOY9.190+0.595
TTM9.7855Y16.350-6.566
5Y16.35010Y19.210-2.859
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD7.132-2.300+9.432
MRQ9.785-2.656+12.441
TTM9.785-2.718+12.503
YOY9.190-4.145+13.335
5Y16.350-6.258+22.608
10Y19.210-6.315+25.525
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of 3SBio Inc:

  • The EOD is 11.319. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 15.529. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 15.529. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD11.319MRQ15.529-4.210
MRQ15.529TTM15.5290.000
TTM15.529YOY35.081-19.552
TTM15.5295Y29.264-13.735
5Y29.26410Y29.163+0.101
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD11.319-2.974+14.293
MRQ15.529-3.306+18.835
TTM15.529-3.508+19.037
YOY35.081-5.613+40.694
5Y29.264-8.378+37.642
10Y29.163-8.873+38.036
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of 3sbio is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.45 means the investor is paying $1.45 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of 3SBio Inc:

  • The EOD is 1.054. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.445. Based on the equity, the company is underpriced. +1
  • The TTM is 1.445. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.054MRQ1.445-0.392
MRQ1.445TTM1.4450.000
TTM1.445YOY1.241+0.204
TTM1.4455Y1.780-0.334
5Y1.78010Y2.063-0.283
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.0541.914-0.860
MRQ1.4452.116-0.671
TTM1.4452.097-0.652
YOY1.2412.881-1.640
5Y1.7803.550-1.770
10Y2.0633.936-1.873
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of 3SBio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.5050.5050%-0.324+164%0.499+1%0.513-2%
Book Value Per Share--5.7425.7420%5.237+10%4.947+16%3.423+68%
Current Ratio--5.4415.4410%5.486-1%4.213+29%4.010+36%
Debt To Asset Ratio--0.4100.4100%0.364+13%0.338+21%0.341+20%
Debt To Equity Ratio--0.6960.6960%0.571+22%0.546+27%0.603+16%
Dividend Per Share--0.1850.1850%-+100%0.051+261%0.096+93%
Eps--0.8480.8480%0.707+20%0.574+48%0.397+114%
Free Cash Flow Per Share--0.5340.5340%0.185+188%0.355+51%0.275+94%
Free Cash Flow To Equity Per Share--0.8510.8510%-0.021+102%0.352+142%0.578+47%
Gross Profit Margin--1.0001.0000%1.0000%-0.149+115%-0.119+112%
Intrinsic Value_10Y_max--5.147--------
Intrinsic Value_10Y_min--1.268--------
Intrinsic Value_1Y_max--0.391--------
Intrinsic Value_1Y_min--0.240--------
Intrinsic Value_3Y_max--1.269--------
Intrinsic Value_3Y_min--0.628--------
Intrinsic Value_5Y_max--2.262--------
Intrinsic Value_5Y_min--0.910--------
Market Cap14755465612.800-37%20243035468.80020243035468.8000%16395310743.500+23%21154072660.094-4%19060530857.885+6%
Net Profit Margin--0.2790.2790%0.259+8%0.230+21%0.234+19%
Operating Margin--0.2780.2780%0.264+5%0.275+1%0.293-5%
Operating Ratio--0.8790.8790%0.879+0%0.824+7%0.766+15%
Pb Ratio1.054-37%1.4451.4450%1.241+16%1.780-19%2.063-30%
Pe Ratio7.132-37%9.7859.7850%9.190+6%16.350-40%19.210-49%
Price Per Share6.050-37%8.3008.3000%6.500+28%8.402-1%7.578+10%
Price To Free Cash Flow Ratio11.319-37%15.52915.5290%35.081-56%29.264-47%29.163-47%
Price To Total Gains Ratio8.773-37%12.03512.0350%-20.059+267%6.166+95%10.916+10%
Quick Ratio--7.2967.2960%5.604+30%4.510+62%3.597+103%
Return On Assets--0.0870.0870%0.086+1%0.076+15%0.079+10%
Return On Equity--0.1480.1480%0.135+9%0.122+21%0.134+10%
Total Gains Per Share--0.6900.6900%-0.324+147%0.550+25%0.609+13%
Usd Book Value--1788422280.7721788422280.7720%1686985572.346+6%1588005174.626+13%1098314478.569+63%
Usd Book Value Change Per Share--0.0640.0640%-0.041+164%0.064+1%0.066-2%
Usd Book Value Per Share--0.7330.7330%0.669+10%0.632+16%0.437+68%
Usd Dividend Per Share--0.0240.0240%-+100%0.007+261%0.012+93%
Usd Eps--0.1080.1080%0.090+20%0.073+48%0.051+114%
Usd Free Cash Flow--166463352.572166463352.5720%59680695.730+179%113688985.339+46%88102604.045+89%
Usd Free Cash Flow Per Share--0.0680.0680%0.024+188%0.045+51%0.035+94%
Usd Free Cash Flow To Equity Per Share--0.1090.1090%-0.003+102%0.045+142%0.074+47%
Usd Market Cap1884272958.755-37%2585035629.3662585035629.3660%2093681181.945+23%2701375078.694-4%2434029790.552+6%
Usd Price Per Share0.773-37%1.0601.0600%0.830+28%1.073-1%0.968+10%
Usd Profit--264191091.986264191091.9860%227817726.949+16%183573671.119+44%127131973.339+108%
Usd Revenue--946375941.466946375941.4660%880507146.264+7%792787483.646+19%537271913.414+76%
Usd Total Gains Per Share--0.0880.0880%-0.041+147%0.070+25%0.078+13%
 EOD+4 -4MRQTTM+0 -0YOY+28 -75Y+30 -610Y+29 -7

3.2. Fundamental Score

Let's check the fundamental score of 3SBio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-157.132
Price to Book Ratio (EOD)Between0-11.054
Net Profit Margin (MRQ)Greater than00.279
Operating Margin (MRQ)Greater than00.278
Quick Ratio (MRQ)Greater than17.296
Current Ratio (MRQ)Greater than15.441
Debt to Asset Ratio (MRQ)Less than10.410
Debt to Equity Ratio (MRQ)Less than10.696
Return on Equity (MRQ)Greater than0.150.148
Return on Assets (MRQ)Greater than0.050.087
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of 3SBio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.137
Ma 20Greater thanMa 505.887
Ma 50Greater thanMa 1005.576
Ma 100Greater thanMa 2006.119
OpenGreater thanClose5.800
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets21,988,704
Total Liabilities9,026,030
Total Stockholder Equity12,962,674
 As reported
Total Liabilities 9,026,030
Total Stockholder Equity+ 12,962,674
Total Assets = 21,988,704

Assets

Total Assets21,988,704
Total Current Assets9,760,925
Long-term Assets12,227,779
Total Current Assets
Cash And Cash Equivalents 2,149,460
Short-term Investments 4,861,054
Net Receivables 1,217,504
Inventory 712,164
Other Current Assets 727,357
Total Current Assets  (as reported)9,760,925
Total Current Assets  (calculated)9,667,539
+/- 93,386
Long-term Assets
Property Plant Equipment 4,707,849
Goodwill 4,140,061
Intangible Assets 1,578,312
Other Assets 663,089
Long-term Assets  (as reported)12,227,779
Long-term Assets  (calculated)11,089,311
+/- 1,138,468

Liabilities & Shareholders' Equity

Total Current Liabilities1,793,931
Long-term Liabilities4,794,323
Total Stockholder Equity12,962,674
Total Current Liabilities
Short Long Term Debt 363,259
Accounts payable 249,495
Other Current Liabilities 1,168,943
Total Current Liabilities  (as reported)1,793,931
Total Current Liabilities  (calculated)1,781,697
+/- 12,234
Long-term Liabilities
Long term Debt Total 4,093,070
Other Liabilities 701,253
Long-term Liabilities  (as reported)4,794,323
Long-term Liabilities  (calculated)4,794,323
+/-0
Total Stockholder Equity
Retained Earnings 9,032,180
Capital Surplus 4,025,612
Total Stockholder Equity (as reported)12,962,674
Total Stockholder Equity (calculated)13,057,792
+/- 95,118
Other
Capital Stock149
Cash And Equivalents2,151,746
Cash and Short Term Investments 7,010,514
Common Stock Shares Outstanding 2,398,513
Liabilities and Stockholders Equity 21,988,704
Net Debt 2,279,282
Net Invested Capital 17,391,416
Net Tangible Assets 7,244,301
Net Working Capital 7,966,994
Property Plant and Equipment Gross 6,109,490



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
> Total Assets 
0
0
0
142,475
973,475
952,918
1,053,461
1,186,397
1,311,110
1,470,029
1,268,326
2,306,441
6,630,432
11,038,802
13,752,971
13,839,655
14,809,306
17,678,195
19,212,575
21,988,704
21,988,70419,212,57517,678,19514,809,30613,839,65513,752,97111,038,8026,630,4322,306,4411,268,3261,470,0291,311,1101,186,3971,053,461952,918973,475142,475000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
926,088
942,627
2,762,967
2,240,731
5,276,216
4,437,533
4,596,181
6,679,910
7,790,698
9,760,925
9,760,9257,790,6986,679,9104,596,1814,437,5335,276,2162,240,7312,762,967942,627926,0880000000000
       Cash And Cash Equivalents 
0
0
0
25,372
811,026
439,237
262,767
153,250
245,813
450,557
267,532
105,961
1,298,372
674,380
2,396,410
1,791,104
2,082,142
3,090,128
2,868,077
2,149,460
2,149,4602,868,0773,090,1282,082,1421,791,1042,396,410674,3801,298,372105,961267,532450,557245,813153,250262,767439,237811,02625,372000
       Short-term Investments 
0
0
0
0
0
293,809
477,751
430,734
522,696
422,538
259,656
56,052
81,585
362,172
704,564
68,132
472,163
1,272,862
1,900,023
4,861,054
4,861,0541,900,0231,272,862472,16368,132704,564362,17281,58556,052259,656422,538522,696430,734477,751293,80900000
       Net Receivables 
0
0
0
39,874
65,711
80,904
93,496
169,178
180,420
195,027
235,254
388,616
411,291
822,912
1,668,385
2,046,825
1,302,631
982,965
1,288,830
1,217,504
1,217,5041,288,830982,9651,302,6312,046,8251,668,385822,912411,291388,616235,254195,027180,420169,17893,49680,90465,71139,874000
       Other Current Assets 
0
0
0
14,554
7,411
2,914
3,214
18,556
16,194
19,735
113,164
35,388
31,484
115,611
128,117
145,362
210,067
713,740
752,553
727,357
727,357752,553713,740210,067145,362128,117115,61131,48435,388113,16419,73516,19418,5563,2142,9147,41114,554000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
8,798,071
8,476,755
9,402,122
10,213,125
10,998,285
11,421,877
12,227,779
12,227,77911,421,87710,998,28510,213,1259,402,1228,476,7558,798,0710000000000000
       Property Plant Equipment 
0
0
0
43,142
49,465
78,185
165,120
199,456
198,053
224,245
247,938
373,990
463,580
1,762,813
1,759,669
1,791,961
2,446,324
3,233,074
4,029,347
4,707,849
4,707,8494,029,3473,233,0742,446,3241,791,9611,759,6691,762,813463,580373,990247,938224,245198,053199,456165,12078,18549,46543,142000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
230,597
560,883
4,126,180
3,923,598
4,089,064
4,145,896
3,918,921
3,843,883
4,140,061
4,140,0613,843,8833,918,9214,145,8964,089,0643,923,5984,126,180560,883230,59700000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
3,718
235,188
1,729,349
135,709
81,843
701,596
0
0
0
0
0000701,59681,843135,7091,729,349235,1883,7180000000000
       Intangible Assets 
0
0
0
9,600
9,247
14,119
12,666
52,487
67,063
62,812
42,487
405,545
497,753
2,288,500
2,253,516
2,298,735
2,165,139
1,898,478
1,849,164
1,578,312
1,578,3121,849,1641,898,4782,165,1392,298,7352,253,5162,288,500497,753405,54542,48762,81267,06352,48712,66614,1199,2479,600000
       Other Assets 
0
0
0
1,251
8,537
9,302
11,634
4,486
20,174
10,159
48,095
101,070
615,900
484,869
458,129
520,766
299,488
547,110
579,310
663,089
663,089579,310547,110299,488520,766458,129484,869615,900101,07048,09510,15920,1744,48611,6349,3028,5371,251000
> Total Liabilities 
0
0
0
68,667
29,134
32,523
41,223
50,344
65,904
91,406
186,523
1,362,849
994,967
4,272,460
6,123,325
4,932,285
4,449,987
4,584,860
6,985,125
9,026,030
9,026,0306,985,1254,584,8604,449,9874,932,2856,123,3254,272,460994,9671,362,849186,52391,40665,90450,34441,22332,52329,13468,667000
   > Total Current Liabilities 
0
0
0
39,182
24,760
28,899
38,445
47,942
63,875
78,802
89,541
1,251,889
772,610
1,143,619
2,195,809
1,655,541
1,611,729
1,450,921
1,419,989
1,793,931
1,793,9311,419,9891,450,9211,611,7291,655,5412,195,8091,143,619772,6101,251,88989,54178,80263,87547,94238,44528,89924,76039,182000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
617,429
405,000
518,461
1,087,466
570,328
483,957
360,151
0
0
00360,151483,957570,3281,087,466518,461405,000617,42900000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
617,429
405,000
518,461
1,087,466
570,328
483,957
360,151
150,189
363,259
363,259150,189360,151483,957570,3281,087,466518,461405,000617,42900000000000
       Accounts payable 
0
0
0
1,769
1,693
1,939
2,736
5,030
6,218
3,765
7,034
25,638
34,444
58,792
274,568
112,915
149,763
203,286
230,407
249,495
249,495230,407203,286149,763112,915274,56858,79234,44425,6387,0343,7656,2185,0302,7361,9391,6931,769000
       Other Current Liabilities 
0
0
0
18,578
23,067
26,960
35,709
42,912
57,657
75,037
33,440
608,822
180,826
121,863
307,414
283,555
264,238
880,477
385,433
1,168,943
1,168,943385,433880,477264,238283,555307,414121,863180,826608,82233,44075,03757,65742,91235,70926,96023,06718,578000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
3,128,841
3,927,516
3,276,744
2,838,258
3,133,939
3,134,789
4,794,323
4,794,3233,134,7893,133,9392,838,2583,276,7443,927,5163,128,8410000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
2,540,682
3,318,665
2,724,343
2,322,000
2,546,961
2,468,126
4,093,070
4,093,0702,468,1262,546,9612,322,0002,724,3433,318,6652,540,6820000000000000
       Other Liabilities 
0
0
0
4,485
4,374
3,624
2,778
2,402
2,029
12,604
96,982
37,339
222,357
588,159
608,851
552,401
516,258
586,978
666,663
701,253
701,253666,663586,978516,258552,401608,851588,159222,35737,33996,98212,6042,0292,4022,7783,6244,3744,485000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
256
1,019
2,098
2,355
0
0
0
0
0
0
0000002,3552,0981,0192560000000000
> Total Stockholder Equity
0
0
0
73,334
943,792
920,395
1,012,238
1,136,053
1,234,369
1,367,565
1,070,578
932,367
5,624,290
6,522,499
7,396,788
8,614,433
9,625,041
10,689,314
12,227,450
12,962,674
12,962,67412,227,45010,689,3149,625,0418,614,4337,396,7886,522,4995,624,290932,3671,070,5781,367,5651,234,3691,136,0531,012,238920,395943,79273,334000
   Common Stock
0
0
0
80
122
121
121
123
124
125
0
0
154
155
156
156
155
155
155
149
1491551551551561561551540012512412312112112280000
   Retained Earnings Total Equity00000000000000000000
   Accumulated Other Comprehensive Income 000-905,144-741,009-615,962-589,086-221,718-154,02700000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
4,552,443
4,547,136
4,568,248
4,585,735
4,553,414
4,297,946
4,152,181
4,025,612
4,025,6124,152,1814,297,9464,553,4144,585,7354,568,2484,547,1364,552,443000000000000
   Treasury Stock0000-40,586000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
-154,208
-162,142
-33,776
158,878
76,665
174,754
203,381
6,391,213
202,481
9,504,733
9,504,733202,4816,391,213203,381174,75476,665158,878-33,776-162,142-154,2080000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue6,859,433
Cost of Revenue-1,187,529
Gross Profit5,671,9045,671,904
 
Operating Income (+$)
Gross Profit5,671,904
Operating Expense-4,842,280
Operating Income2,408,733829,624
 
Operating Expense (+$)
Research Development693,172
Selling General Administrative3,034,558
Selling And Marketing Expenses0
Operating Expense4,842,2803,727,730
 
Net Interest Income (+$)
Interest Income134,700
Interest Expense-663,277
Other Finance Cost-578,179
Net Interest Income49,602
 
Pretax Income (+$)
Operating Income2,408,733
Net Interest Income49,602
Other Non-Operating Income Expenses0
Income Before Tax (EBT)2,274,0332,408,733
EBIT - interestExpense = 1,245,382
2,280,901
2,578,162
Interest Expense663,277
Earnings Before Interest and Taxes (EBIT)1,908,6592,937,310
Earnings Before Interest and Taxes (EBITDA)2,757,131
 
After tax Income (+$)
Income Before Tax2,274,033
Tax Provision-366,016
Net Income From Continuing Ops1,908,0171,908,017
Net Income1,914,885
Net Income Applicable To Common Shares1,914,885
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses105,558
Total Other Income/Expenses Net0-49,602
 

Technical Analysis of 3sbio
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of 3sbio. The general trend of 3sbio is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine 3sbio's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of 3SBio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6.35 < 6.5 < 6.52.

The bearish price targets are: 4.9342465753425 > 4.91 > 4.7960215010142.

Tweet this
3SBio Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of 3SBio Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

3SBio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of 3SBio Inc. The current macd is 0.03598426.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the 3sbio price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for 3sbio. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the 3sbio price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
3SBio Inc Daily Moving Average Convergence/Divergence (MACD) Chart3SBio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of 3SBio Inc. The current adx is 19.30.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy 3sbio shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
3SBio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of 3SBio Inc. The current sar is 5.51.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
3SBio Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of 3SBio Inc. The current rsi is 59.14. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
3SBio Inc Daily Relative Strength Index (RSI) Chart3SBio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of 3SBio Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the 3sbio price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
3SBio Inc Daily Stochastic Oscillator Chart3SBio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of 3SBio Inc. The current cci is 33.20.

3SBio Inc Daily Commodity Channel Index (CCI) Chart3SBio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of 3SBio Inc. The current cmo is 27.05.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
3SBio Inc Daily Chande Momentum Oscillator (CMO) Chart3SBio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of 3SBio Inc. The current willr is -35.71428571.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that 3sbio is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
3SBio Inc Daily Williams %R Chart3SBio Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of 3SBio Inc.

3SBio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of 3SBio Inc. The current atr is 0.24772594.

3SBio Inc Daily Average True Range (ATR) Chart3SBio Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of 3SBio Inc. The current obv is 44,219,712.

3SBio Inc Daily On-Balance Volume (OBV) Chart3SBio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of 3SBio Inc. The current mfi is 45.33.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
3SBio Inc Daily Money Flow Index (MFI) Chart3SBio Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for 3SBio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

3SBio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of 3SBio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.137
Ma 20Greater thanMa 505.887
Ma 50Greater thanMa 1005.576
Ma 100Greater thanMa 2006.119
OpenGreater thanClose5.800
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of 3sbio with someone you think should read this too:
  • Are you bullish or bearish on 3sbio? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about 3sbio? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about 3SBio Inc

I send you an email if I find something interesting about 3SBio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about 3SBio Inc.

Receive notifications about 3SBio Inc in your mailbox!